Galmed Pharma (GLMD) Tops Q1 EPS by 10c

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.15), $0.10 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Canadian National Railway (CNI) Tops Q2 EPS by 15c
• Noodles & Company (NDLS) Tops Q2 EPS by 26c ; Offers Guidance